Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Precision medicine through antisense oligonucleotide-mediated exon skipping

Li, D., Mastaglia, F.L., Fletcher, S. and Wilton, S.D. (2018) Precision medicine through antisense oligonucleotide-mediated exon skipping. Trends in Pharmacological Sciences, 39 (11). pp. 982-994.

Link to Published Version:
*Subscription may be required


It has been well established that some genes contain exons that can be omitted from the mature mRNA without seriously compromising gene function, while protein-truncating or missense mutations in those exons cause serious disease.

Manipulation of dystrophin gene expression through redirecting pre-mRNA processing has given accelerated approval for the treatment of Duchenne muscular dystrophy. Antisense oligomer-induced exon skipping of a selected exon can allow a catastrophically defective dystrophin gene to synthesize a truncated but functional dystrophin isoform.

Targeted exon skipping could be applied to many other inherited gene disorders if the disease-causing mutation is found to occur in an exon whose loss from the mature mRNA would not completely abrogate gene function.

Since genomic deletions of an in-frame exon are rare in many genes, genotype–phenotype correlations are limited to infrequent splice site mutations that lead to exon skipping.

Item Type: Journal Article
Murdoch Affiliation(s): Centre for Comparative Genomics
Publisher: Elsevier (Cell Press)
Copyright: © 2018 Published by Elsevier Ltd
Item Control Page Item Control Page